Form D · Biotechnology

PALOMA PHARMACEUTICALS INC

Jamaica Plain, MA · CIK 0001353255

Offering snapshot reported Sep 10, 2010 · SEC filing

Reported sold
$1.2M
Offering amount: $3M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 30, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 10, 2010Initial$1,200,000No comparison1SEC filing
Sep 2, 2009Initial$500,000No comparison1SEC filing
Jan 29, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Feb 7, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$360K (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-147558
The placement agent fee includes: (i) 10% cash fee on gross proceeds, (ii) 2% non-accountable expense allowance, and (iii) a 7-year warrant for common stock shares.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Newbridge Securities Corporation104065

Source: Form D, filed Sep 10, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James N. Little Director
Linda M. Pullan Director
David Sherris Director, Executive
John M. Sorvillo Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
37 Neillian Crescent
Jamaica Plain, MA, 02130